MAPT and Alzheimer disease: With the notion that FcγRIIb phosphorylation is required for tau phosphorylation and Aβ1-42 neurotoxicity, it is likely that the phosphorylation of FcγRIIb found in AD brains is associated with tau phosphorylation and neuronal loss during AD pathogenesis.